The global market for Peripheral Blood Mononuclear Cells (PBMC) is projected to grow at a CAGR of around 9% during 2020 – 2025


You May Also Like

Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results

BERKELEY HEIGHTS, N.J., March 28, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) ...

Precision Therapeutics to Hold Business Update Conference Call on August 14, 2018

MINNEAPOLIS, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or ...